Clinical Trials Directory

Trials / Unknown

UnknownNCT04305522

Probiotics for the Prophylaxis of Migraine

A Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Two Probiotic Interventions For The Prophylaxis of Migraine in Patients Diagnosed With Episodic Migraine

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Biopolis S.L. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to understand the efficacy of two probiotic interventions as prophylaxes of migraine symptoms in individuals diagnosed with episodic migraine. The primary outcome measure will be migraine days per month, but secondary outcome measures such as use of analgesia, the wider impact of migraine (as assessed through the HIT-6 score) will also be assessed. Finally adverse effects will be evaluated. The study will have three arms: two arms including the two different probiotic preparations and a third placebo arm.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic 1Probiotic mixture with maltodextrin as a carrier.
DIETARY_SUPPLEMENTPlaceboPlacebo comparator with maltodextrin as a carrier.
DIETARY_SUPPLEMENTProbiotic 2Probiotic mixture with maltodextrin as a carrier.

Timeline

Start date
2020-03-02
Primary completion
2021-02-02
Completion
2021-05-02
First posted
2020-03-12
Last updated
2020-03-12

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04305522. Inclusion in this directory is not an endorsement.